---

title: 'NSAIDs and Upper GI Bleed'
authors:
    - 'Michelle Lin, MD'
created: 2011/07/15
updates: null
categories:
    - Gastroenterology
    - Pharmacology
drugs: 'Ibuprofen, Diclofenac, Meloxicam, Indomethacin, Ketoprofen, Naproxen, Piroxicam, Ketorolac, Celecoxib, Aceclofenac, Rofecoxib'

---



# NSAIDs and Upper GI Bleed

-   Stomach and platelets have much more COX-1 receptors than COX-2 receptors.
-   Below are statistics from systematic review on NSAIDs and upper GI complications(bleeding, perforation)

**Ketorolac pearls**

-   Has the highest upper GI complication RR (14.54)
-   Before giving, first check that patients don't have a history of a GI bleed or peptic ulcer

|                        |                    |                 |
|------------------------|--------------------|-----------------|
| **NSAID medication**   | **Relative risk of complication**     | **\[95 % CI\]** |
| COX-1 Inhibitors (all) | 4.5                |  \[3.82-5.31\]  |
|  - <span class="drug">Ibuprofen</span>           | 2.69               | \[2.17-3.33\]   |
|  - <span class="drug">Diclofenac</span>\*        | 3.98               | \[3.36-4.72\]   |
|  - <span class="drug">Meloxicam</span>\*         | 4.15               | \[2.59-6.64\]   |
|  - <span class="drug">Indomethacin</span>\*      | 5.40               | \[4.16-7.00\]   |
|  - <span class="drug">Ketoprofen</span>\*        | 5.57               | \[3.94-7.87\]   |
|  - <span class="drug">Naproxen</span>\*          | 5.63               | \[3.83-8.28\]   |
|  - <span class="drug">Piroxicam</span>           | 9.94               | \[5.99-16.50\]  |
|  - <span class="drug">Ketorolac</span>           | 14.54              | \[5.87-36.04\]  |
| COX-2 Inhibitors (all) | 1.88               | \[0.96-3.71\]   |
|  - <span class="drug">Celecoxib</span>           | 1.42               | \[0.85-2.37\]   |
|  - <span class="drug">Aceclofenac</span>         | 1.44               | \[0.65-3.2\]    |
|  - <span class="drug">Rofecoxib</span>           | 2.12               | \[1.59-2.84\]   |

*\* = Estimated relative risk*

## Risk Factors for Upper GI Complication

1.  <span class="aglmd-moreinfo ui-moreinfo" data-iid="53aa2488d35d3ae92e001f47">Longer drug half-life</span>
2.  Slow-release formulation
3.  <span class="aglmd-moreinfo ui-moreinfo" data-iid="53aa2488d35d3ae92e001f48">Dual inhibition of COX-1 and COX-2 isoenzymes</span> 

Relative risk is greatest when first starting medication (&lt; 30 days)

## References

-   [Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010 Jun;62(6):1592-601](http://www.ncbi.nlm.nih.gov/pubmed/?term=20178131)
